Induction of Transient Virus Replication Facilitates Antigen-Independent Isolation of SIV-Specific Monoclonal Antibodies.

CD8b depletion SIV antiretroviral therapy interruption monoclonal antibodies rhesus macaques

Journal

Molecular therapy. Methods & clinical development
ISSN: 2329-0501
Titre abrégé: Mol Ther Methods Clin Dev
Pays: United States
ID NLM: 101624857

Informations de publication

Date de publication:
13 Mar 2020
Historique:
received: 05 12 2019
accepted: 26 01 2020
entrez: 22 2 2020
pubmed: 23 2 2020
medline: 23 2 2020
Statut: epublish

Résumé

Structural characterization of the HIV-1 Envelope (Env) glycoprotein has facilitated the development of Env probes to isolate HIV-specific monoclonal antibodies (mAbs). However, preclinical studies have largely evaluated these virus-specific mAbs against chimeric viruses, which do not naturally infect non-human primates, in contrast to the unconstrained simian immunodeficiency virus (SIV)mac239 clone. Given the paucity of native-like reagents for the isolation of SIV-specific B cells, we examined a method to isolate SIVmac239-specific mAbs without using Env probes. We first activated virus-specific B cells by inducing viral replication after the infusion of a CD8β-depleting mAb or withdrawal of antiretroviral therapy in SIVmac239-infected rhesus macaques. Following the rise in viremia, we observed 2- to 4-fold increases in the number of SIVmac239 Env-reactive plasmablasts in circulation. We then sorted these activated B cells and obtained 206 paired Ab sequences. After expressing 122 mAbs, we identified 14 Env-specific mAbs. While these Env-specific mAbs bound to both the SIVmac239 SOSIP.664 trimer and to infected primary rhesus CD4

Identifiants

pubmed: 32083148
doi: 10.1016/j.omtm.2020.01.010
pii: S2329-0501(20)30021-8
pmc: PMC7021589
doi:

Types de publication

Journal Article

Langues

eng

Pagination

225-237

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI108421
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI052056
Pays : United States
Organisme : NIAID NIH HHS
ID : R37 AI052056
Pays : United States
Organisme : NIAID NIH HHS
ID : R56 AI049120
Pays : United States
Organisme : NIH HHS
ID : R24 OD011161
Pays : United States
Organisme : NIH HHS
ID : K01 OD023032
Pays : United States
Organisme : NCRR NIH HHS
ID : R24 RR015371
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI073961
Pays : United States
Organisme : NCI NIH HHS
ID : HHSN261200800001E
Pays : United States
Organisme : NIAID NIH HHS
ID : F30 AI147881
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI094420
Pays : United States
Organisme : CCR NIH HHS
ID : HHSN261200800001C
Pays : United States
Organisme : NIH HHS
ID : P51 OD011106
Pays : United States

Informations de copyright

© 2020 The Author(s).

Références

Nat Med. 1999 Nov;5(11):1270-6
pubmed: 10545993
J Virol. 1992 Apr;66(4):2067-75
pubmed: 1548752
J Virol. 2015 May;89(10):5318-29
pubmed: 25740988
Science. 1999 Feb 5;283(5403):857-60
pubmed: 9933172
J Exp Med. 1999 Mar 15;189(6):991-8
pubmed: 10075982
J Immunol Methods. 2015 Jan;416:69-83
pubmed: 25445326
Science. 1992 Dec 18;258(5090):1938-41
pubmed: 1470917
Nat Rev Microbiol. 2013 Dec;11(12):877-83
pubmed: 24162027
J Virol. 2003 Sep;77(18):9993-10003
pubmed: 12941910
Cell. 2014 Sep 11;158(6):1243-1253
pubmed: 25215485
Immunity. 2012 Sep 21;37(3):412-25
pubmed: 22999947
J Virol. 1998 Jan;72(1):164-9
pubmed: 9420212
Science. 2016 Sep 2;353(6303):1045-1049
pubmed: 27540005
Nat Med. 2016 Apr;22(4):362-8
pubmed: 26998834
J Virol. 2012 Mar;86(6):2911-8
pubmed: 22238318
Nature. 2008 May 29;453(7195):667-71
pubmed: 18449194
AIDS Res Hum Retroviruses. 1999 Dec 10;15(18):1691-701
pubmed: 10606092
Expert Rev Vaccines. 2018 Feb;17(2):127-144
pubmed: 29307225
Ther Adv Vaccines Immunother. 2018 Oct 12;6(4):61-68
pubmed: 30345419
Nature. 2012 Nov 1;491(7422):129-33
pubmed: 23023123
J Virol. 2009 Nov;83(22):11514-27
pubmed: 19726517
J Virol. 2017 Oct 27;91(22):
pubmed: 28878078
J Immunol Methods. 2012 Dec 14;386(1-2):85-93
pubmed: 22989932
Immunity. 2019 Oct 15;51(4):724-734.e4
pubmed: 31586542
Nat Rev Immunol. 2018 May;18(5):297-308
pubmed: 29379211
Nature. 2013 Nov 14;503(7475):224-8
pubmed: 24172905
Nat Commun. 2015 Apr 10;6:6565
pubmed: 25858157
PLoS Pathog. 2016 Apr 11;12(4):e1005537
pubmed: 27064278
PLoS Pathog. 2015 Aug 06;11(8):e1005090
pubmed: 26248318
PLoS Pathog. 2019 Sep 30;15(9):e1008015
pubmed: 31568531
Annu Rev Immunol. 2016 May 20;34:635-59
pubmed: 27168247
Proc Natl Acad Sci U S A. 2006 Mar 14;103(11):4005-10
pubmed: 16537476
Virology. 2001 Nov 10;290(1):59-73
pubmed: 11883006
Science. 2009 Oct 9;326(5950):285-9
pubmed: 19729618
Science. 1985 Jun 7;228(4704):1201-4
pubmed: 3159089
Lancet HIV. 2019 Dec;6(12):e831-e859
pubmed: 31439534
PLoS Pathog. 2018 Feb 23;14(2):e1006913
pubmed: 29474444
N Engl J Med. 2016 Nov 24;375(21):2019-2021
pubmed: 27959740
Immunol Rev. 2017 Jan;275(1):285-295
pubmed: 28133801
PLoS Pathog. 2013 Sep;9(9):e1003618
pubmed: 24068931
Immunity. 2016 Jul 19;45(1):31-45
pubmed: 27438765
J Virol. 2015 Nov;89(21):10802-20
pubmed: 26292326
mBio. 2019 Jul 2;10(4):
pubmed: 31266872
Nature. 2013 Nov 14;503(7475):277-80
pubmed: 24172896
Nat Protoc. 2013 Jun;8(6):1073-87
pubmed: 23660756
Proc Natl Acad Sci U S A. 2019 Jan 29;116(5):1739-1744
pubmed: 30642966
J Virol. 1997 Feb;71(2):1608-20
pubmed: 8995688
Sci Transl Med. 2017 Oct 4;9(410):
pubmed: 28978754
Nat Med. 2009 Aug;15(8):901-6
pubmed: 19448633
Proc Natl Acad Sci U S A. 2016 Jun 14;113(24):E3413-22
pubmed: 27247400
J Virol. 2019 Feb 19;93(5):
pubmed: 30541854
PLoS One. 2012;7(7):e42209
pubmed: 22848744
J Virol. 2007 Apr;81(7):3465-76
pubmed: 17251286
Nature. 2000 Sep 21;407(6802):386-90
pubmed: 11014195
AIDS Res Hum Retroviruses. 2017 Aug;33(8):843-858
pubmed: 28503929
Nature. 2016 May 5;533(7601):105-109
pubmed: 27120156
AIDS Res Hum Retroviruses. 1998 Sep 20;14(14):1253-62
pubmed: 9764909
Nat Protoc. 2010 Feb;5(2):239-46
pubmed: 20134424
Nat Rev Microbiol. 2012 Dec;10(12):852-67
pubmed: 23154262
Cold Spring Harb Perspect Med. 2012 Jun;2(6):a007310
pubmed: 22675663
J Virol. 2013 May;87(10):5800-11
pubmed: 23487459
Nat Immunol. 2018 Nov;19(11):1179-1188
pubmed: 30333615
Sci Transl Med. 2019 Jul 24;11(502):
pubmed: 31341061
Sci Transl Med. 2017 Sep 20;9(408):
pubmed: 28931655

Auteurs

Nuria Pedreño-Lopez (N)

Department of Pathology, University of Miami Leonard M. Miller School of Medicine, Miami, FL 33136, USA.

Christine M Dang (CM)

Department of Pathology, University of Miami Leonard M. Miller School of Medicine, Miami, FL 33136, USA.

Brandon C Rosen (BC)

Department of Pathology, University of Miami Leonard M. Miller School of Medicine, Miami, FL 33136, USA.
Medical Scientist Training Program, University of Miami Leonard M. Miller School of Medicine, Miami, FL 33136, USA.

Michael J Ricciardi (MJ)

Department of Pathology, University of Miami Leonard M. Miller School of Medicine, Miami, FL 33136, USA.

Varian K Bailey (VK)

Department of Pathology, University of Miami Leonard M. Miller School of Medicine, Miami, FL 33136, USA.

Martin J Gutman (MJ)

Department of Pathology, University of Miami Leonard M. Miller School of Medicine, Miami, FL 33136, USA.

Lucas Gonzalez-Nieto (L)

Department of Pathology, University of Miami Leonard M. Miller School of Medicine, Miami, FL 33136, USA.

Matthias G Pauthner (MG)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Consortium for HIV/AIDS Vaccine Development (Scripps CHAVI-ID), The Scripps Research Institute, La Jolla, CA 92037, USA.

Khoa Le (K)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Consortium for HIV/AIDS Vaccine Development (Scripps CHAVI-ID), The Scripps Research Institute, La Jolla, CA 92037, USA.

Ge Song (G)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.

Raiees Andrabi (R)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.

Kim L Weisgrau (KL)

Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI 53715, USA.

Nicholas Pomplun (N)

Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI 53715, USA.

José M Martinez-Navio (JM)

Department of Pathology, University of Miami Leonard M. Miller School of Medicine, Miami, FL 33136, USA.

Sebastian P Fuchs (SP)

Department of Pathology, University of Miami Leonard M. Miller School of Medicine, Miami, FL 33136, USA.

Jens Wrammert (J)

Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30317, USA.

Eva G Rakasz (EG)

Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI 53715, USA.

Jeffrey D Lifson (JD)

AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21701, USA.

Mauricio A Martins (MA)

Department of Pathology, University of Miami Leonard M. Miller School of Medicine, Miami, FL 33136, USA.

Dennis R Burton (DR)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Consortium for HIV/AIDS Vaccine Development (Scripps CHAVI-ID), The Scripps Research Institute, La Jolla, CA 92037, USA.
Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02139, USA.

David I Watkins (DI)

Department of Pathology, University of Miami Leonard M. Miller School of Medicine, Miami, FL 33136, USA.

Diogo M Magnani (DM)

Department of Pathology, University of Miami Leonard M. Miller School of Medicine, Miami, FL 33136, USA.

Classifications MeSH